Bristol-Myers Squibb Company
SUBSTITUTED INDOLE COMPOUNDS

Last updated:

Abstract:

Disclosed are compounds of Formula (I) or salts thereof, wherein Ring Het, R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases. ##STR00001##

Status:
Application
Type:

Utility

Filling date:

13 Nov 2018

Issue date:

19 Aug 2021